IN8bio Inc (INAB)
0.8383
-0.06
(-6.78%)
USD |
NASDAQ |
Jun 28, 16:00
0.8383
0.00 (0.00%)
After-Hours: 20:00
IN8bio Cash from Investing (Quarterly): -0.071M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.071M |
| December 31, 2023 | -0.072M |
| September 30, 2023 | -0.077M |
| June 30, 2023 | -0.022M |
| March 31, 2023 | -0.429M |
| December 31, 2022 | -1.263M |
| September 30, 2022 | -1.764M |
| June 30, 2022 | -0.425M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.253M |
| December 31, 2021 | -0.156M |
| September 30, 2021 | -0.153M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.764M
Minimum
Sep 2022
--
Maximum
Sep 2020
-0.3123M
Average
-0.077M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| Jaguar Health Inc | -- |
| Aptevo Therapeutics Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.919M |
| Cash from Financing (Quarterly) | -0.277M |
| Free Cash Flow | -24.06M |
| Free Cash Flow Per Share (Quarterly) | -0.1846 |
| Free Cash Flow Yield | -83.23% |